Dr. John C. ShershowAdult ADHD PsychiatryCall (212) 265-4310
Menu

Key points

  • The CRC's list of Medicinal Cannabis Program qualifying conditions includes anxiety, PTSD and Tourette syndrome, but not ADHD, as of October 2026.
  • A 2026 meta-analysis in Psychiatry Research found trivial to no effect of cannabinoids on ADHD in randomized trials, with mostly very low certainty.
  • A 2024 meta-analysis estimated lifetime cannabis use disorder in 26.9% of people with ADHD, about 2.9 times the general population's risk.
  • N.J.S.A. 24:6I-52 bars adverse action based solely on cannabis metabolites from lawful use, but employers may still test and keep drug-free workplaces.
  • On DOT tests, a medical review officer may not treat a state medical marijuana recommendation as a reason to report a negative (49 CFR 40.151(e)).

Cannabis is legal for adults 21 and older in New Jersey, and many adults with ADHD have heard that it helps with focus or restlessness. Legal and effective are different questions. This page covers what the research shows as of October 2026, what New Jersey's Medicinal Cannabis Program does and does not include, how cannabis fits with prescribed ADHD medication, and where cannabis use meets workplace rules. It is general information, not advice to use or avoid any substance.

What is legal in New Jersey

According to the New Jersey Cannabis Regulatory Commission (CRC), adults 21 and older can buy recreational cannabis at a licensed dispensary, and adults and minors with a qualifying medical condition may join the Medicinal Cannabis Program. The CRC also says driving under the influence of any substance is illegal. State legality does not change federal drug-testing rules for DOT-regulated jobs, covered below.

Is ADHD a qualifying condition for medical cannabis?

No. As of October 2026, the CRC's list of approved qualifying conditions for the Medicinal Cannabis Program is:

  • amyotrophic lateral sclerosis, anxiety, cancer, chronic pain, dysmenorrhea, glaucoma
  • inflammatory bowel disease (including Crohn's disease), intractable skeletal muscular spasticity, migraine
  • multiple sclerosis, muscular dystrophy, opioid use disorder, HIV/AIDS
  • post-traumatic stress disorder, seizure disorder (including epilepsy), terminal illness with a prognosis of less than 12 months, and Tourette syndrome

ADHD is not on that list. Anxiety is, and anxiety often occurs alongside ADHD, but an authorization would be for the anxiety, made by a registered provider. The CRC says a participating provider must hold an active New Jersey license, an active New Jersey CDS registration and an active physical practice in the state, and must have a bona fide relationship with the patient, such as a relationship of at least one year or at least four visits for the condition.

What the research shows about cannabis and ADHD

StudyWhat it looked atWhat it found
Bharat et al., Psychiatry Research, 2026Systematic review and meta-analysis of 82 experimental and 118 observational studies of cannabinoids in adults with ADHD and other conditionsTrivial to no effect on ADHD in randomized trials. Certainty was mostly very low, and the authors said the evidence is insufficient to support cannabinoids as first-line treatment.
Black et al., Lancet Psychiatry, 2019Systematic review and meta-analysis of cannabinoids for six mental disordersOnly three ADHD studies, with one randomized trial of 30 people. The authors found scarce evidence that cannabinoids improve ADHD.
Cooper et al., European Neuropsychopharmacology, 2017Pilot randomized trial of a THC and CBD spray in 30 adults with ADHDNo significant difference on the primary outcome. Some secondary measures looked better, but not after correction for multiple testing. The authors called it not definitive.
Froude et al., Journal of Psychiatric Research, 2024Meta-analysis of cannabis use disorder in people with ADHD (14 studies)Estimated lifetime prevalence of cannabis use disorder of 26.9% and current prevalence of 19.2%, with about 2.9 times the risk of the general population.

The plain reading: there is no good trial evidence that cannabis treats ADHD, and people with ADHD appear to be at higher risk of cannabis use disorder. Reports that cannabis "helps" are mostly from observational studies, which the 2026 review rated at high risk of bias. Evidence-based options are covered in what studies show about ADHD treatment, and the link between ADHD and substance use in ADHD and substance use in New Jersey.

Cannabis alongside ADHD medication

The CRC warns that cannabis can interact with prescription medications in unexpected and harmful ways, can make some medications less effective, and can increase the effects of some prescriptions. It advises telling your doctor and other health care providers about cannabis use, especially if you take prescription drugs.

For ADHD care specifically, three practical points follow:

  • Tell your prescriber. Cannabis use is part of the substance history that New Jersey rules expect a prescriber to take before starting a controlled substance (N.J.A.C. 13:35-7.6(b)). Leaving it out makes it harder to judge whether a medication is working or causing side effects.
  • Expect questions about sleep, anxiety and mood. An adult ADHD evaluation looks at substances, sleep and other explanations for symptoms, so this is part of the conversation.
  • Do not use cannabis to manage stimulant side effects on your own. Raise the side effect with the prescriber, who can adjust the plan.

Disclosing cannabis use does not by itself rule out ADHD treatment. It does shape which options are safest, and it is better discussed openly than discovered later.

Cannabis, drug tests and work in New Jersey

New Jersey's adult-use law includes an employment section, N.J.S.A. 24:6I-52. Employers may not take adverse action against someone because they do or do not use cannabis items, or solely because cannabinoid metabolites from lawful use show up in a test. Employers may still keep a drug-free workplace, prohibit use and impairment at work, and test on reasonable suspicion, after an accident, and through random, pre-employment or regular screening. The CRC's 2022 interim guidance says a positive cannabis test "alone is insufficient to support an adverse employment action," but may be enough when combined with documented signs of impairment during work hours.

Two limits matter:

  • DOT-regulated jobs. Under 49 CFR 40.151(e), a medical review officer must not verify a marijuana test as negative based on a physician's recommendation under a state medical marijuana law. A New Jersey medical cannabis card does not help on a DOT test.
  • Federal contractors. N.J.S.A. 24:6I-52 lets an employer under a federal contract revise its rules to match federal law if the state provisions would have a provable adverse impact.

For medical cannabis patients, the CRC points to N.J.S.A. 24:6I-6.1 in the Jake Honig Act and the New Jersey Supreme Court's 2020 decision in Wild v. Carriage Funeral Holdings, and suggests asking human resources or an employment lawyer about your employer's policy. How prescribed stimulants are handled on drug tests is a separate question, covered in ADHD medication and drug tests in New Jersey.

Questions to bring to an appointment

  • "I use cannabis about this often. Does that change which ADHD medications make sense for me?"
  • "Could cannabis be affecting the symptoms we are evaluating, such as focus, sleep or motivation?"
  • "What should I watch for if I use cannabis while taking this medication?"
  • "If I want to cut back, what support is available?"

If you want help with cannabis or other substance use, the CRC lists ReachNJ at 1-844-732-2465 for finding addiction treatment. For accidental cannabis poisoning, it lists the New Jersey Poison Center at 1-800-222-1222. In a mental health crisis, call or text 988.

Dr. Shershow is a psychiatrist who focuses on adult ADHD and is licensed in New York and New Jersey. The adult ADHD evaluation covers substances, sleep and other explanations for symptoms, and ends with what it found and the treatment options that fit. The New Jersey ADHD medication rules page explains how stimulant prescriptions work in the state.

Questions

Can I get a New Jersey medical cannabis card for ADHD?

Not for ADHD itself. ADHD is not on the Cannabis Regulatory Commission's list of qualifying conditions as of October 2026. Anxiety and PTSD are on the list, and an authorization for those would come from a provider registered with the program.

Does cannabis help ADHD symptoms?

Randomized trials have not shown that it does. A 2026 meta-analysis found trivial to no effect on ADHD, and a 2019 review found scarce evidence. People with ADHD also have higher rates of cannabis use disorder.

Can I use cannabis while taking ADHD medication?

Discuss it with your prescriber before combining them. New Jersey's cannabis regulator warns that cannabis can interact with prescription medications and advises telling your health care providers about cannabis use.

Will using cannabis stop a psychiatrist from treating my ADHD?

Not automatically. Substance use is part of the history a prescriber must take, and it shapes which treatment options are safest. Being open about it helps the evaluation.

Can my New Jersey employer fire me for legal cannabis use?

N.J.S.A. 24:6I-52 bars adverse action for lawful off-duty use or solely for cannabis metabolites, but employers can ban use and impairment at work and test in several situations. DOT-regulated jobs and some federal contractors follow federal rules.

Sources

  1. NJ Cannabis Regulatory Commission: FAQs, legal cannabis in New Jersey
  2. NJ Cannabis Regulatory Commission: Medicinal Cannabis Program, healthcare providers and qualifying conditions
  3. NJ Cannabis Regulatory Commission: New patient registration
  4. Bharat et al., Psychiatry Research 2026;365:117380: cannabis and cannabinoids for mental and substance use disorders, systematic review and meta-analysis
  5. Black et al., Lancet Psychiatry 2019;6(12):995-1010: cannabinoids for the treatment of mental disorders, systematic review and meta-analysis
  6. Cooper et al., European Neuropsychopharmacology 2017;27(8):795-808: cannabinoids in ADHD, a randomised controlled trial
  7. Froude et al., Journal of Psychiatric Research 2024;172:391-401: prevalence of cannabis use disorder in ADHD, meta-analysis
  8. NJ Cannabis Regulatory Commission: Safe and responsible consumption
  9. Cornell Legal Information Institute: N.J.A.C. 13:35-7.6, limitations on prescribing controlled dangerous substances
  10. FindLaw: N.J.S.A. 24:6I-52, cannabis and employment under CREAMMA (current as of January 1, 2024)
  11. NJ Cannabis Regulatory Commission: Guidance on Workplace Impairment (September 2022)
  12. NJ Cannabis Regulatory Commission: Workplace and DUI laws
  13. Cornell Legal Information Institute: 49 CFR 40.151, what MROs are prohibited from doing

Questions about ADHD medication in New Jersey?

Dr. Shershow manages ADHD medication when it is appropriate, and the office can explain how visits work for patients located in New Jersey. Call, or leave your number and the office will call you.

Prefer a call back?

Leave your number and the office will call you to talk about scheduling.

No health details needed. Not for emergencies: call or text 988, or call 911.

Request a ConsultCall (212) 265-4310